Sandbox g11

## FDA Pregnancy Categories

[edit | edit source]

Antimicrobial Agent  | Pregnancy Category  | Drug Class

|
|

Penicillins | B | Antibacterial agents
Beta lactam/Beta lactam inhibitor | B | Antibacterial agents
Cephalosporins | B | Antibacterial agents
Aztreonam | B | Antibacterial agents
Meropenem | B | Antibacterial agents
Ertapenem | B | Antibacterial agents
Doripenem | B | Antibacterial agents
Clindamycin | B | Antibacterial agents
Daptomycin | B | Antibacterial agents
Fosfomycin | B | Antibacterial agents
Erythromycin | B | Antibacterial agents
Azithromycin | B | Antibacterial agents
Metronidazole | B | Antibacterial agents
Nitrofurantoin | B | Antibacterial agents
Imipenem/Cilastatin | C | Antibacterial agents
Chloramphenicol | C | Antibacterial agents
Ciprofloxacin | C | Antibacterial agents
Ofloxacin | C | Antibacterial agents
Levofloxacin | C | Antibacterial agents
Gatifloxacin | C | Antibacterial agents
Gemifloxacin | C | Antibacterial agents
Moxifloxacin | C | Antibacterial agents
Colistin | C | Antibacterial agents
Linezolid | C | Antibacterial agents
Clarithromycin | C | Antibacterial agents
Rifaximin | C | Antibacterial agents
Sulfonamides/Trimethoprim | C | Antibacterial agents
Telavancin | C | Antibacterial agents
Telithromycin | C | Antibacterial agents
Tinidazole | C | Antibacterial agents
Vancomycin | C | Antibacterial agents
Amikacin | D | Antibacterial agents
Gentamicin | D | Antibacterial agents
Isepamicin | D | Antibacterial agents
Netilmicin | D | Antibacterial agents
Streptomycin | D | Antibacterial agents
Tobramycin | D | Antibacterial agents
Tetracyclines | D | Antibacterial agents
Tigecycline | D | Antibacterial agents
Rifabutin | B | Antimycobacterial agents
Capreomycin | C | Antimycobacterial agents
Dapsone | C | Antimycobacterial agents
Isoniazid | C | Antimycobacterial agents
Pyrazinamide | C | Antimycobacterial agents
Rifampin | C | Antimycobacterial agents
Quinine | X | Antimycobacterial agents
Thalidomide | X | Antimycobacterial agents
Amphotericin B | B | Antifungal agents
Anidulafungin | C | Antifungal agents
Caspofungin | C | Antifungal agents
Fluconazole | C | Antifungal agents
Itraconazole | C | Antifungal agents
Ketoconazole | C | Antifungal agents
Flucytosine | C | Antifungal agents
Micafungin | C | Antifungal agents
Posaconazole | C | Antifungal agents
Terbinafine | B | Antifungal agents
Voriconazole | D | Antifungal agents
Nitazoxanide | B | Antiparasitic agents
Praziquantel | B | Antiparasitic agents
Albendazole | C | Antiparasitic agents
Mebendazole | C | Antiparasitic agents
Artemether | C | Antiparasitic agents
Lumefantrine | C | Antiparasitic agents
Atovaquone | C | Antiparasitic agents
Proguanil | C | Antiparasitic agents
Chloroquine | C | Antiparasitic agents
Eflornithine | C | Antiparasitic agents
Ivermectin | C | Antiparasitic agents
Mefloquine | C | Antiparasitic agents
Pentamidine | C | Antiparasitic agents
Pyrimethamine | C | Antiparasitic agents
Quinidine | C | Antiparasitic agents
Miltefosine | X | Antiparasitic agents
Acyclovir | B | Antiviral agents
Atazanavir | B | Antiviral agents
Darunavir | B | Antiviral agents
Didanosine | B | Antiviral agents
Emtricitabine | B | Antiviral agents
Enfuvirtide | B | Antiviral agents
Etravirine | B | Antiviral agents
Famciclovir | B | Antiviral agents
Maraviroc | B | Antiviral agents
Nelfinavir | B | Antiviral agents
Ritonavir | B | Antiviral agents
Saquinavir | B | Antiviral agents
Telbivudine | B | Antiviral agents
Tenofovir | B | Antiviral agents
Valacyclovir | B | Antiviral agents
Abacavir | C | Antiviral agents
Adefovir | C | Antiviral agents
Amantadine | C | Antiviral agents
Cidofovir | C | Antiviral agents
Delavirdine | C | Antiviral agents
Entecavir | C | Antiviral agents
Fosamprenavir | C | Antiviral agents
Foscarnet | C | Antiviral agents
Ganciclovir | C | Antiviral agents
Indinavir | C | Antiviral agents
Interferons | C | Antiviral agents
Lamivudine | C | Antiviral agents
Lopinavir | C | Antiviral agents
Ritonavir | C | Antiviral agents
Nevirapine | C | Antiviral agents
Oseltamivir | C | Antiviral agents
Raltegravir | C | Antiviral agents
Rimantadine | C | Antiviral agents
Stavudine | C | Antiviral agents
Tipranavir | C | Antiviral agents
Valganciclovir | C | Antiviral agents
Zalcitabine | C | Antiviral agents
Zanamivir | C | Antiviral agents
Zidovudine | C | Antiviral agents
Efavirenz | D | Antiviral agents
Ribavirin | X | Antiviral agents
Category  | Definition

|

A | Adequate and well-controlled studies in pregnant women have failed to demonstrate a risk to the fetus in the first trimester of pregnancy
B | Animal reproduction studies have failed to demonstrate a risk to the fetus and there are no adequate and well-controlled studies in pregnant women
C | Animal reproduction studies have shown an adverse effect on the fetus, if there are no adequate and well-controlled studies in humans, and if the benefits from the use of the drug in pregnant women may be acceptable despite its potential risks
D | There is positive evidence of human fetal risk based on adverse reaction data from investigational or marketing experience or studies in humans, but the potential benefits from the use of the drug in pregnant women may be acceptable despite its potential risks
X | Studies in animals or humans have demonstrated fetal abnormalities or if there is positive evidence of fetal risk based on adverse reaction reports from investigational or marketing experience, or both, and the risk of the use of the drug in a pregnant woman clearly outweighs any possible benefit